Patent Assignment
Reel/Frame 041926/0956
Assignment of Assignor's Interest
Recorded: 2017-04-07
Pages: 7
Assignors
ABDEL-MEGUID, SHERIN SALAHELDIN
Executed: 2015-10-02
ELSHOURBAGY, NABIL
Executed: 2015-10-02
MEYERS, HAROLD
Executed: 2015-09-28
MOUSA, SHAKER A.
Executed: 2015-09-28
Assignee
SHIFA BIOMEDICAL CORPORATION
ONE GREAT VALLEY PARKWAY, SUITE 8, MALVERN, PENNSYLVANIA, 19355
Covered Property
(1)
Anti-Proprotein Convertase Subtilisin Kexin Type 9 (Anti-PCSK9) Compounds and Methods of Using the Same in the Treatment and/or Prevention of Cardiovascular Diseases
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Confirmatory License
Jul 24, 2023
From: SHIFA BIOMEDICAL CORPORATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 064366/0537 →
Confirmatory License
Jul 25, 2023
From: SHIFA BIOMEDICAL CORPORATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 064380/0957 →